Rydapt

Generic name:midostaurin [ MYE-doe-STAW-rin ]
Drug class:Multikinase inhibitors

Medically reviewed by Philip Thornton, DipPharm. Last updated on Feb 4, 2021.

What is Rydapt?

Rydapt is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Rydapt is used together with other cancer medicines to treat acute myeloid leukemia.

Rydapt is also used to treat certain rare blood disorders, including systemic mastocytosis with mast cell leukemia or other cancers affecting the blood, bone marrow, or lymphatic tissue.

Warnings

Both men and women using Rydapt should use effective birth control to prevent pregnancy. Midostaurin can harm an unborn baby if the mother or father is using this medicine.

Before taking this medicine

You should not use Rydapt if you are allergic to midostaurin.

Tell your doctor if you have ever had:

• lung disease or breathing problems.

You may need to have a negative pregnancy test before starting this treatment.

Midostaurin can harm an unborn baby or cause birth defects if the mother or the father is using Rydapt.

• If you are a woman, do not use midostaurin if you are pregnant. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 4 months after your last dose. If you are pregnant, your name may be listed on a pregnancy registry to track the effects of midostaurin on the baby.

• If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.